Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer

Lung cancer is the leading cause of cancer-related deaths, demanding improvement in current treatment modalities to reduce the mortality rates. Lung cancer is divided into two major classes with non-small cell lung cancer representing ~84% of lung cancer cases. One strategy widely used to treat non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, A.S., Bains, M., Agredo, A., Kasinski, A.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854807/
https://www.ncbi.nlm.nih.gov/pubmed/32681833
http://dx.doi.org/10.1016/j.bcp.2020.114154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854807/
https://www.ncbi.nlm.nih.gov/pubmed/32681833
http://dx.doi.org/10.1016/j.bcp.2020.114154

Ejemplares similares